Worse, such proposals may severely damage the ability of companies such as ours to invest in cutting edge research and development, including investment in the many talented scientists who dedicate their lives to finding life changing medical advances.
FORBES: Merck CEO: Health Care Beyond the Fiscal Cliff Requires Structural Changes